BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 2091880)

  • 1. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients.
    Guillausseau PJ; Charles MA; Godard V; Timsit J; Chanson P; Paolaggi F; Peynet J; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Res; 1990 Mar; 13(3):127-31. PubMed ID: 2091880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Level of serum fructosamine in Saudi diabetic patients.
    Ajabnoor MA; Zawawi TH; Marzouki KM; Marzouki ZM
    Acta Diabetol Lat; 1990; 27(2):105-12. PubMed ID: 2378195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2,070 simultaneous determinations of blood glucose, glucosylated hemoglobin and fructosamine as index of metabolic control in 519 diabetic patients].
    Gómez Reyes D; Gea T; Rojas Hidalgo E
    Rev Clin Esp; 1989 Nov; 185(7):354-8. PubMed ID: 2623250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fructosamine with glycosylated hemoglobin and plasma proteins as measures of glycemic control.
    Smart LM; Howie AF; Young RJ; Walker SW; Clarke BF; Smith AF
    Diabetes Care; 1988 May; 11(5):433-6. PubMed ID: 3391095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum fructosamine level as a marker of glycemic control in diabetic patients with and without a residual C-peptide secretion.
    Buysschaert M; Ketelslegers JM; Mpoy M; Galanti L; Pirson F; Pouthier F; Lambert AE
    Diabetes Res; 1987 Nov; 6(3):129-31. PubMed ID: 3436113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fructosamine and glycated haemoglobin measurements in diabetic control.
    Hindle EJ; Rostron GM; Clark SA; Gatt JA
    Arch Dis Child; 1986 Feb; 61(2):113-7. PubMed ID: 3954436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of serum fructosamine as index of short-term glycemic control in diabetic outpatients.
    Cefalu WT; Parker TB; Johnson CR
    Diabetes Care; 1988 Sep; 11(8):662-4. PubMed ID: 3219971
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of HbA1 and fructosamine in diagnosis of glucose-tolerance abnormalities.
    Guillausseau PJ; Charles MA; Paolaggi F; Timsit J; Chanson P; Peynet J; Godard V; Eschwege E; Rousselet F; Lubetzki J
    Diabetes Care; 1990 Aug; 13(8):898-900. PubMed ID: 2209329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fructosamine and glycated haemoglobin to verify self blood glucose monitoring data in diabetic pregnancy.
    Parfitt VJ; Clark JD; Turner GM; Hartog M
    Diabet Med; 1993 Mar; 10(2):162-6. PubMed ID: 8458194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of serum fructosamine and HbA1 as markers for metabolic control in patients with changing insulin regimens.
    Steen G; Weber RF
    Diabetes Res; 1990 Apr; 13(4):177-82. PubMed ID: 2134209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of assays of glycosylated haemoglobin and serum fructosamine compared: use of data on biological variation.
    Howey JE; Bennet WM; Browning MC; Jung RT; Fraser CG
    Diabet Med; 1989 Dec; 6(9):793-6. PubMed ID: 2533039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of fructosamine and glycosylated haemoglobin measurements at a diabetic clinic.
    Cockram CS; Pui PC; Keung CC; Moon YS; Swaminathan R
    Diabetes Res Clin Pract; 1990 Apr; 9(1):43-8. PubMed ID: 2351039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum fructosamine/haemoglobin A1 ratio predicts the future changes in haemoglobin A1 in type 2 (non-insulin dependent) diabetic patients.
    MacRury SM; Kilpatrick ES; Paterson KR; Dominiczak MH
    Clin Chim Acta; 1991 May; 199(1):51-8. PubMed ID: 1934502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term performance of the fructosamine assay.
    Dominiczak MH; Macrury SM; Orrell JM; Paterson KR
    Ann Clin Biochem; 1988 Nov; 25 ( Pt 6)():627-33. PubMed ID: 3254102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of diabetic control by using hemoglobin A1 and fructosamine.
    Sridama V; Hansasuta P; Pasatrat S; Bunnag S
    J Med Assoc Thai; 1990 Mar; 73(3):130-5. PubMed ID: 2380644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of plasma fructosamine in the assessment of diabetic control.
    Saeed BO; elWali NM; Atabani GS; Elmahdi EM; Mukhtar E
    Trop Geogr Med; 1991; 43(1-2):51-4. PubMed ID: 1750129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of the determination of fructosamine in monitoring diabetic patients].
    Vinci VS; Masotti G; Citro G; De Marca S; Quaglia C; Galasso R
    Medicina (Firenze); 1990; 10(1):25-7. PubMed ID: 2381275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes in serum fructosamine do not parallel those in glycated haemoglobin in young adults with insulin-dependent diabetes.
    Fisken RA; Chan AW; Hanlon A; MacFarlane IA
    Clin Chim Acta; 1990 Oct; 191(1-2):79-86. PubMed ID: 2073735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fructosamine and HbA1c during monitoring of glucose levels in diabetes].
    Dezier JF; Barbier P; Le Treut A; Allannic H
    Diabete Metab; 1988; 14(5):635-40. PubMed ID: 3234587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of fructosamine and glycated haemoglobin in children with type 1 (insulin-dependent) diabetes mellitus.
    Mullis P; Völkle H; Sigrist V; Zuppinger K
    Diabetologia; 1988 Jun; 31(6):351-4. PubMed ID: 3417057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.